BioHarvest Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioHarvest Ltd. - overview
Established
2007
Location
Rehovot, -, Israel
Primary Industry
Food
About
BioHarvest Ltd. specializes in biotechnology, focusing on the innovative production of plant-based compositions through proprietary technology aimed at enhancing health and wellness for consumers. Founded in 2007 in Rehovot, Israel, BioHarvest Ltd. operates in the biotechnology sector, producing health-oriented products derived from plant cells.
The CEO, Hagay Yochi, leads the company, which has undergone strategic developments to establish itself in the market. BioHarvest has engaged in one known funding deal, with Greensoil Investments acquiring the company on January 12, 2012. BioHarvest Sciences operates at the forefront of the biotechnology sector, specializing in the innovative production of plant-based compositions through its proprietary Botanical Synthesis technology. The company's flagship product, VINIA®, derived from red grape cells, is known for its high concentrations of Piceid Resveratrol, promoting blood circulation and energy levels.
In addition, BioHarvest offers a Contract Development and Manufacturing Organization (CDMO) service unit that caters to pharmaceutical, nutraceutical, and cosmeceutical industries, allowing partners to utilize its technology for developing proprietary plant-based molecules, targeting markets in North America and Europe. BioHarvest Sciences generates revenue through multiple channels, including direct-to-consumer sales of VINIA® and partnerships via its CDMO services. The company employs a subscription model for its nutraceutical products, enhancing consumer loyalty. Recent collaborations, such as with Tate & Lyle, focus on developing innovative plant-based ingredients, with revenues stemming from royalties and production contracts, supporting a diverse revenue model.
BioHarvest plans to develop new nutraceutical products, leveraging its proprietary technology to meet consumer demands for wellness solutions. The company is targeting expansion into additional international markets by 2024, focusing on regions beyond North America and Europe. Recent funding from the acquisition is intended to support these initiatives, enhancing product development and market entry strategies.
Current Investors
Greensoil Investments
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Medicinal Chemicals & Botanicals
Website
www.bioharvest.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
BioHarvest Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | BioHarvest Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.